Based on Haselmeier’s i-pen platform, launch of the 300 unit insulin pen BerliPen® areo 3 to the German market has been announced by Berlin-Chemie.

Released in April, the BerliPen® areo 3 is used with six different insulins (Berlinsulin H and Liprolog types) in the treatment of type 1 and 2 diabetes.

Key features of this third-generation BerliPen® are an optimized dose indicator, innovative low-friction mechanism for smooth injection release in addition to an enhanced feeling of safety by means of audible and tactile dose settings. The BerliPen® areo 3 comes onto the market with five different metallic colours, black, blue, green, red and yellow.

Project manager of Haselmeier Tobias Alberstetter says: "The declared aim of Haselmeier was to enable the product launch of our valuable partner BerlinChemie, the BerliPen® areo 3 project was brought to a successful conclusion with the issuance of the declaration of conformity. Ultimately, we were successful in implementing this by joining forces; setting a milestone both for Haselmeier and Berlin-Chemie".